Haier Biomedical Announces the Acquisition of Labtech International’s UK Cold Chain Business

Haier Biomedical, the subsidiary of Haier, an international manufacturer with annual sales of $25 billion, is pleased to announce the acquisition of Labtech International’s UK cold chain business. The details of the acquisition have not been announced.

Paul Young, CEO of Haier Biomedical said: “We are very pleased to have acquired the UK cold chain business from Labtech. This acquisition allows us to provide more support to our UK customers directly as well as providing greater vision of the needs of our customers to our research and development teams. In this way we can be confident of supplying our customers with continued improvements year on year.

Dr Brian Page, CEO of Labtech International said, “we have been selling Haier Ultracold freezers to our customers in the UK for more than 6 years now and we have been very impressed with Haier’s commitment to service, quality and product improvement. We are very pleased to have Haier Biomedical

continuing to increase their resources and support for our UK customers.”

Haier Biomedical have been developing and pioneering low energy ultra cold freezers as well as expanding their portfolio of products in recent years. The closer relationship with customers in the UK will permit the company to identify even more benefits which can be engineered into the products by its R&D and engineering teams, while the company can also focus on building increased local support.

For further information on this acquisition, please contact Richard Jafrato, General Manager, Haier Biomedical UK Ltd.